Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GLCE - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARMC4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
PRKCQ - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYB5R1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDE3B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HIST1H4G - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
PLXDC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
POU4F1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ERC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ST8SIA4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DSC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ITGA2B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RBFOX1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADD2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NADSYN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WT1-AS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NKX3-1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DDO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on